COVID-19 Seroprevalence Study in French Guiana

NACompletedINTERVENTIONAL
Enrollment

3,541

Participants

Timeline

Start Date

July 15, 2020

Primary Completion Date

September 24, 2021

Study Completion Date

September 24, 2021

Conditions
Coronavirus InfectionSevere Acute Respiratory SyndromeSARS-CoV InfectionCovid19
Interventions
PROCEDURE

Blood sample

Blood sample

Trial Locations (5)

Unknown

Centre Hospitalier Andrée Rosemon, Cayenne

Laboratoire de biologie méicale, Institut Pasteur de la Guyane, Cayenne

Laboratoires Eurofins Guyane, Cayenne

Laboratoire de biologie médicale de Kourou, Kourou

Laboratoire de biologie médicale du Centre hospitalier de Saint-Laurent du Maroni, Saint-Laurent-du-Maroni

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Institut Pasteur de la Guyane

UNKNOWN

collaborator

Laboratoire de biologie médicale, Institut Pasteur de la Guyane

UNKNOWN

collaborator

Laboratoire de biologie médicale de Kourou, French Guiana

UNKNOWN

collaborator

Laboratoire de biologie médicale du Centre hospitalier de Saint-Laurent du Maroni, French Guiana

UNKNOWN

collaborator

Eurofins

INDUSTRY

collaborator

Centres Délocalisés de Prévention et de Soins, Centre Hospitalier Andrée Rosemon de Cayenne, Frech Guiana

UNKNOWN

lead

Institut Pasteur

INDUSTRY

NCT04490850 - COVID-19 Seroprevalence Study in French Guiana | Biotech Hunter | Biotech Hunter